![Jennifer Hodge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Jennifer Hodge
Antiguos cargos conocidos de Jennifer Hodge.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Nile Therapeutics, Inc. /Old/ | Corporate Officer/Principal | 17/06/1996 | 11/10/2007 |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | 01/01/2000 | 01/01/2007 |
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 29/04/2010 | - |
CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2007 | - |
Formación de Jennifer Hodge.
The University of Edinburgh | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Hodge
- Experiencia